Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
LINCOLN PHARMACEUTICALS LTD. - Board Meeting Intimation for Inter-Alia To Consider And Approve The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended On September 30, 2020.
Download < Back
26 Oct 2020
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 ,inter alia, to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended on September 30, 2020 along with any other business, if any.&lt;BR&gt; &lt;BR&gt; Further, in continuation to our disclosure on closure of trading window dated September 30, 2020, the trading window for dealing / trading in the securities of the Company by the designated persons was closed from October 01, 2020 and shall remain closed till 48 hours after the announcement of financials results.
View all announcements for LINCOLN PHARMACEUTICALS LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you